Chartwell Investment Partners, LLC Eagle Pharmaceuticals, Inc. Transaction History

Chartwell Investment Partners, LLC

$2.91 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 26, 2022	SELL	$44.58 - $52.6 $7.72 Million - $9.11 Million	-173,202 Closed	0 $0
Q4 2021 Feb 15, 2022	SELL	$45.82 - $56.9 $149,373 - $185,494	-3,260 Reduced 1.85%	173,202 $8.82 Million
Q3 2021 Nov 16, 2021	SELL	$43.79 - $55.78 $826,667 - $1.05 Million	-18,878 Reduced 9.66%	176,462 $9.84 Million
Q2 2021 Jul 19, 2021	SELL	$36.86 - $44.5 $76,042 - $91,803	-2,063 Reduced 1.05%	195,340 $8.36 Million
Q1 2021 May 03, 2021	BUY	$40.32 - $50.97 $69,511 - $87,872	1,724 Added 0.88%	197,403 $8.24 Million
Q4 2020 Feb 09, 2021	SELL	$41.72 - $51.34 $103,882 - $127,836	-2,490 Reduced 1.26%	195,679 $9.11 Million
Q3 2020 Nov 16, 2020	SELL	$37.02 - $51.28 $76,890 - $106,508	-2,077 Reduced 1.04%	198,169 $8.42 Million
Q2 2020 Jul 29, 2020	BUY	$43.24 - $55.02 $374,544 - $476,583	8,662 Added 4.52%	200,246 $9.61 Million
Q1 2020 Apr 30, 2020	BUY	$34.37 - $60.07 $123,560 - $215,951	3,595 Added 1.91%	191,584 $8.81 Million
Q4 2019 Jan 29, 2020	BUY	$54.32 - $64.31 $70,616 - $83,603	1,300 Added 0.7%	187,989 $11.3 Million
Q3 2019 Oct 29, 2019	SELL	$53.25 - $59.98 $536,227 - $603,998	-10,070 Reduced 5.12%	186,689 $10.6 Million
Q2 2019 Aug 19, 2019	SELL	$46.61 - $58.45 $467,265 - $585,961	-10,025 Reduced 4.85%	196,759 $11 Million
Q1 2019 Apr 11, 2019	SELL	$38.66 - $51.82 $363,519 - $487,263	-9,403 Reduced 4.35%	206,784 $10.4 Million
Q4 2018 Feb 01, 2019	BUY	$36.72 - $67.73 $2.22 Million - $4.1 Million	60,578 Added 38.93%	216,187 $8.71 Million
Q3 2018 Nov 08, 2018	SELL	$66.65 - $83.86 $255,336 - $321,267	-3,831 Reduced 2.4%	155,609 $10.8 Million
Q2 2018 Aug 09, 2018	BUY	$51.25 - $76.62 $8.17 Million - $12.2 Million	159,440 New	159,440 $12.1 Million

Others Institutions Holding EGRX

# of Institutions

Shares Held

8.6M

Call Options Held

Put Options Held

100

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Chartwell Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chartwell Investment Partners, LLC with notifications on news.

Account